RYLD ETF

RYLD ETF
$15.54
See how much of RYLD you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

RSSL is RYLD's largest holding at 100.02% of the fund as of Sep 15, 2026. RYLD is Global X Russell 2000 Covered Call ETF.

Showing top 11 of 11 holdings · as of Sep 15, 2026
RYLD holdings, by weight
#TickerNameWeightCumulativeSharesMkt value
1
RSSL
Global X Russell 2000 Etf
100.02%
100.0%12,136,506$1.37B
2—Cash
0.04%
100.1%547,113$547.1K
3—Inhibrx Inc
0.00%
100.1%15,798$10.3K
4—Cartesian Therapeutics Inc
0.00%
100.1%1-
5—Canadian Dollar
0.00%
100.1%7,088$5.1K
6—Novartis Ag - Cvr
0.00%
100.1%26,043$10.2K
7—Omniab Inc - 15.00 Earnout
0.00%
100.1%2,421-
8—Omniab Inc - 12.5 Earnout
0.00%
100.1%2,421-
9
RAIN
Rain Oncology Inc
0.00%
100.1%1-
10—Other Payable & Receivables
-0.02%
100.0%-217,214$-217214
11—Rut Us 09/18/26 C3005
-0.05%
100.0%-4,703$-681935
Not reported for this fund: share changes, sector, industry.

RYLD ETF All Holdings

RYLD holdings total 12 positions. The top 10 holdings account for 100.0% of the fund, led by Global X Russell 2000 Etf at 100.0%, Cash at 0.0%, Inhibrx Inc at 0.0%.

RYLD portfolio concentration is relatively high, with the top 10 representing 100.0% of total assets.

RYLD sectors provide a detailed breakdown. RYLD overlap shows how holdings compare to other funds in your portfolio.

RYLD ETF Holdings

11 of 12 holdings

  • 1

    Global X Russell 2000 Etf

    RSSLUnknown
    100.02%
  • 2

    Cash

    Other
    0.04%
  • 3

    Inhibrx Inc

    INBXUnknown
    0.00%
  • 4

    Cartesian Therapeutics Inc

    RNACUnknown
    0.00%
  • 5

    Canadian Dollar

    Other
    0.00%
  • 6

    Novartis Ag - Cvr

    Other
    0.00%
  • 7

    Omniab Inc - 15.00 Earnout

    Other
    0.00%
  • 8

    Omniab Inc - 12.5 Earnout

    OABIUnknown
    0.00%
  • 9

    Rain Oncology Inc

    RAINUnknown
    0.00%
  • 10

    Other Payable & Receivables

    Other
    -0.02%
  • 11

    Rut Us 09/18/26 C3005

    Other
    -0.05%